GPT and Thrombocytopenia: The most frequent grade ≥ 3 treatment-emergent adverse events (TEAEs) were thrombocytopenia (12.9%) and elevated serum concentrations of aspartate aminotransferase (4.3%) and alanine aminotransferase (2.9%).